ATN classification and clinical progression in subjective cognitive declineJarith L. Ebenau, Wiesje M. van der Flier, Sander C.J. Verfaillie et al.|Neurology|2020Cited by 200
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesBetty M. Tijms, Pieter Jelle Visser, Eleonora M. Vromen et al.|Nature Aging|2024Cited by 195